Artificial Intelligence Stocks Worth Watching – March 14th

SentinelOne, Tempus AI, and Firefly Neuroscience are the three Artificial Intelligence stocks to watch today, according to MarketBeat’s stock screener tool. Artificial intelligence stocks are shares of companies whose core business involves developing, supplying, or relying heavily on AI technologies—such as machine learning platforms, AI chips, data services, or AI-powered applications. For investors, they represent a thematic way to gain exposure to the expected growth of AI-driven products and services, but often come with higher valuations, rapid technological change, and increased regulatory and execution risk. These companies had the highest dollar trading volume of any Artificial Intelligence stocks within the last several days.

SentinelOne (S)

SentinelOne, Inc. operates as a cybersecurity provider in the United States and internationally. Its Singularity Platform delivers an artificial intelligence-powered autonomous threat prevention, detection, and response capabilities across an organization's endpoints, cloud workloads, and identify credentials, which enables seamless and autonomous protection against a spectrum of cyber threats.

Tempus AI (TEM)

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Firefly Neuroscience (AIFF)

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.